Treatment Effect of Intravitreal Aflibercept Injection by Baseline Factors in Moderately Severe-to-Severe NPDR in PANORAMA

Related

• 

  Expert Panel: AI

  Mark S. Humayun, MD, PhD

  Devinder S Chauhan, MD FRCOphth FRANZCO

  Ursula M. Schmidt-Erfurth, MD

  Jennifer I. Lim, MD, FARVO, FASRS

  Royce WS Chen, MD

  Annual Meeting Talks

  2024

• 

  High-dose Aflibercept Therapy in nAMD and DME Eyes With Suboptimal Response to Standard Dose of Anti-VEGF Therapy: A Retrospective Analysis

  Jared S. Nielsen, MD, MBA

  Annual Meeting Talks

  2020

• 

  Progressive Quantitative Outer Retinal Optical Coherence Tomography Abnormalities in Early Diabetic Retinopathy Compared with Controls

  Jennifer I. Lim, MD, FARVO, FASRS

  Annual Meeting Talks

  2022